¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference) : 2018-10-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference) : 2018-10-12
±³À°ÀÏÀÚ : 2018-10-12
±³À°Àå¼Ò : ÀÓÆ丮¾óÆ縮½ºÈ£ÅÚ 7Ãþ µÎº£È¦  
±³À°ÁÖÁ¦ : 2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference)      
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸  
´ã´çÀÚ : ½É¹Î°æ
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@lungca.or.kr      
±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000 ºñȸ¿ø 70,000 ÇöÀåµî·Ï ȸ¿ø: 60,000 ºñȸ¿ø 80,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 09:00~09:20 Current controversies and future perspectives in immuno-oncology biomarker testing  ±èÈ¿Áø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 09:20~09:40 Beyond PD-L1: Who will get benefit from checkpoint inhibitors?  ±èÀº°æ(BMS) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 09:40~10:00 Genomic biomarkers for cancer immunotherapy  ½ÉÈ¿¼·(¿¬¼¼ÀÇ´ë) 
Åä·Ð 10¿ù 12ÀÏ µÎº£È¦ 10:00~10:10 Åä·Ð  () 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 10:10~10:55 Evolution of Immunotherapy Decision-Making for Non-Small Cell Lung Cancer  David R. Gandara(UC Davis Comprehensive Cancer Center) 
È޽Ġ10¿ù 12ÀÏ µÎº£È¦ 10:55~11:15 È޽Ġ () 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 11:15~11:45 Dealing with adverse events of immunotherapy : Case  ÀÓ¼±¹Î(Â÷ÀÇ°ú´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 11:45~12:15 Multiple choice questions, but one decision  ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 12:15~13:00 Immune check point inhibitors in advanced NSCLC: Patient selection, Successes and challenges  Á¶Àº°æ(°¡ÃµÀÇ´ë) 
È޽Ġ10¿ù 12ÀÏ µÎº£È¦ 13:00~13:15 È޽Ġ () 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 13:15~14:00 Applying Advances in Genetics and Immunology to Develop Effective Immunotherapy for NSCLC Regardless of Tumor Mutational Burden  Bernard A. Fox(Earle A Chiles Research Institute Robert W. Franz Cancer Center) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 14:00~14:20 Plasticity of innate lymphoid cells (ILCs) in tumor microenvironment  Á¤µÎÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 14:20~14:40 Immuno-biology of immune checkpoint receptors  ÇÏ»óÁØ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 14:40~15:00 Immunological techniques in the study of human T cells  Á¤¹Î°æ(KAIST) 
Åä·Ð 10¿ù 12ÀÏ µÎº£È¦ 15:00~15:10 Åä·Ð  () 
È޽Ġ10¿ù 12ÀÏ µÎº£È¦ 15:10~15:30 È޽Ġ () 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 15:30~15:50 Issues of Immune Checkpoint Inhiibitors as Neo-adjuvant and Adjuvnat Therapy; Surgeon's View  ±èÈ«°ü(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 15:50~16:10 Issues of Immune Checkpoint Inhibitors as Concurrent and Consolidation Therapy: Radiation Oncologist's View  ¼Û½Ã¿­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 12ÀÏ µÎº£È¦ 16:10~16:30 Artificial intelligence, role as a clinical decision support system  ¹Ú°Ç¿í(°è¸íÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference) : 2018-10-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¸Á¸·ÁúȯÀÇ À¯ÀüÀÚ °Ë»ç) : 2018-10-12
´ÙÀ½±Û 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-10-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20880 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 33 2024-05-27
20879 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 50 2024-05-27
20878 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 36 2024-05-27
20877 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 54 2024-05-27
20876 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 27 2024-05-27
20875 ¼­¿ï 2024³â ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ Á¦3ȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 34 2024-05-27
20874 ¼­¿ï °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ILD School 202 : 2024-06-29 0 21 2024-05-27
20873 ¼­¿ï 2024 ´ëÇѼö¼ú°¨¿°ÇÐȸ Çмú´ëȸ : 2024-06-29 0 35 2024-05-27
20872 ¼­¿ï ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 2 : 2024-06-28 0 17 2024-05-27
20871 ¼­¿ï 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28 0 33 2024-05-27
20870 °æ±â 2024³â Á¦ 2ȸ ÆÄÁֽà ÀÇ»çȸ ÃÑȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 14 2024-05-27
20869 ¼­¿ï (¿Â¶óÀÎ) Á¦95ȸ ¼Ò¾Æû¼Ò³â°ú ¿¬¼ö°­Á : 2024-06-28 0 54 2024-05-27
20868 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-28 0 23 2024-05-27
20867 ¼­¿ï ´ëÇѹýÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-28 0 26 2024-05-27
20866 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 34 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷